146 related articles for article (PubMed ID: 8241672)
1. Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
Fjellestad-Paulsen A; Laborde K; Kindermans C; Czernichow P
Acta Paediatr; 1993 Sep; 82(9):752-7. PubMed ID: 8241672
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
3. Influence of cardiopulmonary bypass on water balance hormones in children.
Burch M; Lum L; Elliott M; Carter N; Slater D; Smith A; Ationu A
Br Heart J; 1992 Sep; 68(3):309-12. PubMed ID: 1327039
[TBL] [Abstract][Full Text] [Related]
4. Renal prostaglandins and water balance: studies in normal volunteer subjects and in patients with central diabetes insipidus.
Düsing R; Herrmann R; Glänzer K; Vetter H; Overlack A; Kramer HJ
Clin Sci (Lond); 1981 Jul; 61(1):61-7. PubMed ID: 6265142
[TBL] [Abstract][Full Text] [Related]
5. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus.
Kamoi K; Ebe T; Kobayashi O; Ishida M; Sato F; Arai O; Tamura T; Takagi A; Yamada A; Ishibashi M
J Clin Endocrinol Metab; 1990 May; 70(5):1385-90. PubMed ID: 2139879
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide in dehydrated Long-Evans rats and Brattleboro rats.
Ogawa K; Henry MA; Tange J; Woodcock EA; Johnston CI
Kidney Int; 1987 Mar; 31(3):760-5. PubMed ID: 2952831
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin inhibits diuresis induced by water immersion in humans.
Farrow S; Banta G; Schallhorn S; May R; Mers A; Cadaret L; Rydstedt L; Lockette W
J Appl Physiol (1985); 1992 Sep; 73(3):932-6. PubMed ID: 1400058
[TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
10. Oral desmopressin treatment of central diabetes insipidus in children.
Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
[TBL] [Abstract][Full Text] [Related]
11. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
Fjellestad A; Czernichow P
Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
[TBL] [Abstract][Full Text] [Related]
12. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
Jespersen B; Sørensen SS; Pedersen EB
Nephrol Dial Transplant; 1991; 6(6):402-9. PubMed ID: 1652115
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
Tanae A; Shimizu K; Yoshida S
Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
[TBL] [Abstract][Full Text] [Related]
15. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
16. Nocturnal polyuria in monosymptomatic nocturnal enuresis refractory to desmopressin treatment.
Kamperis K; Rittig S; Jørgensen KA; Djurhuus JC
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1232-40. PubMed ID: 16804103
[TBL] [Abstract][Full Text] [Related]
17. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
18. Prolonged antidiuresis by 1-desamino-8-D-arginine vasopressin (DDAVP): correlation to its plasma levels and nephrogenous cyclic AMP production.
Katayama S; Itabashi A; Yamaji T
Endocrinol Jpn; 1980 Jun; 27(3):363-70. PubMed ID: 6254752
[TBL] [Abstract][Full Text] [Related]
19. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
Kinter LB; Beeuwkes R
Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
[TBL] [Abstract][Full Text] [Related]
20. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
Cunnah D; Ross G; Besser GM
Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
